Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
基本信息
- 批准号:10488001
- 负责人:
- 金额:$ 2.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressArthritisAwardBiotinylationCCL2 geneCalibrationCellsCommunitiesComplementComputer ModelsDataDiabetic NephropathyDiseaseG-Protein-Coupled ReceptorsGoalsHispanicInflammatoryInternshipsLigandsMediatingMedicalMedicineMentorsMethodologyModelingNerve DegenerationParentsPathologyPhysiologyResearchRoleScienceScientistServicesSignal TransductionStructureStudentsSystemTalentsTherapeuticTimeTissuesTrainingTraining SupportTraining and EducationTraumatic Brain InjuryWorkbasecareercareer developmentcell motilitychemokinechemokine receptorcomputational platformdesensitizationdesignexperienceextracellularin silicomigrationmonocytemonocyte chemoattractant protein 1 receptornon-alcoholic fatty liver diseaseparent grantphosphoproteomicsreceptorresearch and developmenttherapeutic targettraffickingundergraduate studentvolunteer
项目摘要
Abstract
Monocyte migration into tissues, guided by inflammatory chemokine CCL2 and its G protein-coupled receptor
CCR2, is key to normal physiology and to the pathology of numerous diseases including neurodegeneration,
traumatic brain injury, arthritis, diabetic nephropathy, and non-alcoholic fatty liver disease. However, despite its
therapeutic significance, the role of CCR2 in monocyte function is still poorly understood. In addition to its well-
recognized ability to promote cell movement, CCR2 possesses a different, equally important but largely
unappreciated function: it scavenges and removes chemokines from the extracellular medium. Scavenging may
enable CCR2-expressing cells to move along gradients of increasing chemokine concentration without
desensitizing; it may also mediate intercellular coordination and crosstalk by altering the availability of CCL2 and
other chemokines to their receptors on different cells.
The present application is a supplement to R01 GM136202 titled “Signaling circuits that drive cell movement and
ligand scavenging by chemokine receptor CCR2,” and awarded to PIs Handel and Kufareva for the period of
2020-24. The objective of the parent proposal is to achieve a comprehensive and predictive systems-based
understanding of CCR2 migration and scavenging functions. The experimental and computational advances that
the applicants made on all three Aims of the parent R01 during its first year revealed the need for better,
systematic and quantitative platforms for computational modeling of CCR2 trafficking, interactome, and phospho-
signaling. Many of these findings materialized as a result of the work of a talented Hispanic undergraduate
student, Alexis Lona, who is currently a part-time volunteer intern in the Kufareva lab but seeks a more extensive
and structured training/engagement. This supplement will enable Alexis to best address the growing
computational needs of the parent R01 while at the same time enhancing his research capability and ultimately
helping him achieve his long-term career goal of becoming a medical scientist.
The applicant will pursue two scientific Aims, both related to Aims 2 and 3 of the parent R01. In Aim S1, he will
build a framework for in silico agent-based modeling of CCR2 trafficking and interactions and for model
calibration against unbiased proximity biotinylation data. In Aim S2, the trainee will develop a methodology for
the modeling of phospho-signal propagation downstream of CCR2 from multifactorial time-resolved
phosphoproteomics data. The scientific Aims are complemented by a comprehensive training and mentoring
plan designed to structure and facilitate the research and career development of the candidate.
As a Hispanic student, Alexis will promote diversity in science by being part of a research lab, and medicine by
becoming a medical scientist and professional. With proper education and training, Alexis will be able to further
science as a service to others while simultaneously practicing medicine in his community. Moreover, by sharing
his experiences in science and research Alexis intends to inform and inspire others from similar backgrounds.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracy M Handel其他文献
Tracy M Handel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracy M Handel', 18)}}的其他基金
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
这是一场拉锯战:CXCR4 和 ACKR3 对淋巴细胞趋化剂 CXCL12 反应的结构、后果和抑制
- 批准号:
10393668 - 财政年份:2021
- 资助金额:
$ 2.74万 - 项目类别:
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
这是一场拉锯战:CXCR4 和 ACKR3 对淋巴细胞趋化剂 CXCL12 反应的结构、后果和抑制
- 批准号:
10597645 - 财政年份:2021
- 资助金额:
$ 2.74万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10559615 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10727691 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10627751 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10397636 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
9917599 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
GPCR 激酶、Gβγ 和抑制蛋白对促进趋化因子受体 ACKR3 的转移的调节
- 批准号:
10162570 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2
趋化因子受体 CCR2 驱动细胞运动和配体清除的信号通路
- 批准号:
10360504 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Insights into Activation Mechanisms of G Protein-Coupled and Atypical β-Arrestin-Coupled Chemokine Receptors
深入了解 G 蛋白偶联和非典型 β-抑制蛋白偶联趋化因子受体的激活机制
- 批准号:
9899267 - 财政年份:2019
- 资助金额:
$ 2.74万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 2.74万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 2.74万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 2.74万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 2.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 2.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 2.74万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 2.74万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 2.74万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 2.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 2.74万 - 项目类别:














{{item.name}}会员




